| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120114659 | Antibodies for Guanylyl Cyclase Receptors - Monoclonal antibodies that act as potentiators, stimulators and agonists of guanylyl cyclase receptors are disclosed. | 05-10-2012 |
| 20120088298 | IKKALPHA AND IKKBETA SPECIFIC INHIBITORS - A method for modulating NF-κB dependent gene transcription in a cell comprised of modulating IKKα and IKKβ protein and protein activity in the cell. The present invention also provides siRNA compositions and methods thereof for modulating NF-κB dependent gene transcription. | 04-12-2012 |
| 20110301201 | DABIGATRAN FOR PERCUTANEOUS INTERVENTIONAL CARDIAC CATHETERISATION - The invention relates to a new use of dabigatran etexilate of formula (I) optionally in the form of the pharmaceutically acceptable salts thereof, and new medicament formulations which may be used for this purpose. | 12-08-2011 |
| 20110282693 | CLINICAL MANAGEMENT SYSTEM AND METHOD - An automated data processing method for obtaining clinical data for safety, efficacy, and adverse event assessments pertaining to a therapy prescribed for the treatment of a malady, comprising the step of receiving at a location remote from a plurality of patients outcome digital information pertaining to the outcome of therapies performed on said patients, and for the efficient delivery of medications to a patient ordered pursuant to an electronic prescription from a dispensary optimized for delivery of the medication. | 11-17-2011 |
| 20110124099 | IKKALPHA AND IKKBETA SPECIFIC INHIBITORS - A method for modulating NF-κB dependent gene transcription in a cell comprised of modulating IKKα and IKKβ protein and protein activity in the cell. The present invention also provides siRNA compositions and methods thereof for modulating NF-κB dependent gene transcription. | 05-26-2011 |
| 20110060608 | CLINICAL MANAGEMENT SYSTEM AND METHOD - An automated data processing method for obtaining clinical data for safety, efficacy, and adverse event assessments pertaining to a therapy prescribed for the treatment of a malady, comprising the step of receiving at a location remote from a plurality of patients outcome digital information pertaining to the outcome of therapies performed on said patients, and for the efficient delivery of medications to a patient ordered pursuant to an electronic prescription from a dispensary optimized for delivery of the medication. | 03-10-2011 |
| 20100152167 | PYRIMIDINE DERIVATIVES - The present invention relates to trisubstituted pyrimidines of formula (I) | 06-17-2010 |
| 20100136550 | Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory Disease - Methods for the diagnosis of inflammatory bowel diseases and the identification of agents useful in the treatment of such diseases based upon the agent's effect on reducing Pim-2 expression. | 06-03-2010 |
| 20090325988 | Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof - Compounds of Formula (I) | 12-31-2009 |
| 20090171089 | 1,6 NAPHTHRIDINES USEFUL AS INHIBITORS OF SYK KINASE - Disclosed are compounds of formula (I): | 07-02-2009 |
| 20090110669 | METHODS FOR IMPROVING CELL LINE ACTIVITY IN IMMUNOISOLATION DEVICES - Methods for maintaining and improving the secretory activity of cells housed in immunoisolation devices. | 04-30-2009 |
| 20090099159 | Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide Compounds - A method of treating or preventing of a disease or condition associated with an increased level of isoforms of amyloid β peptides (Aβ) and/or with a changed ratio of levels of Aβ isoforms and/or with the formation of plaques containing amyloid β peptide (Aβ) isoforms in a mammal comprising administering to said mammal an therapeutically effective amount of a compound selected from the formulas Ia, Ib | 04-16-2009 |
| 20090088571 | Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides - Disclosed is a multi-step process for preparing a compound of Formula I: | 04-02-2009 |
| 20080215374 | CLINICAL MANAGEMENT SYSTEM AND METHODS - An automated data processing method for obtaining clinical data for safety, efficacy, and adverse event assessments pertaining to a therapy prescribed for the treatment of a malady, comprising the step of receiving at a location remote from a plurality of patients outcome digital information pertaining to the outcome of therapies performed on said patients, and for the efficient delivery of medications to a patient ordered pursuant to an electronic prescription from a dispensary optimized for delivery of the medication. | 09-04-2008 |
